Showing 116 of 116on this page. Filters & sort apply to loaded results; URL updates for sharing.116 of 116 on this page
Biogen Competitors | Comparably
Biogen Rare-Disease Drug Stalls As New Competitor Gains Traction | WBUR ...
Code of Business Conduct | Biogen
Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion ...
Biogen Buys Biotech Firm HI-Bio to Boost Its Immunology Portfolio
Why Biogen may have the most lucrative product in pharmaceutical history
Biogen sees flat 2024 sales, pick up in Alzheimer's drug demand | Reuters
Biogen shares soar after patent victory
Biogen - Generis
Biogen - Biogen Puts 250 Million Toward Goal Of Going Fossil Fuel Free ...
Biogen strikes deal with Versant-backed biotech to expand immune ...
Biogen Photos and Premium High Res Pictures - Getty Images
Community Lab: 20 years of inspiring future scientists | Biogen
How The Aducanumab Surprise Helped Biogen Stock
Biogen receives FDA approval for breakthrough ALS treatment: 'Pivotal ...
Biogen and Samsung Bioepis Heat Up the Lucrative AMD Market with First ...
Biogen Announces New Global Headquarters at Kendall Common, Cambridge
Earnings Preview: What To Expect From Biogen On Thursday
Biogen to consolidate operations at new global headquarters in Cambridge
Our U.S. Legacy | Biogen
Biogen investing $2 billion in North Carolina ahead of 2028 product ...
Biogen and Moderna shares show how biotech ETFs may look similar but ...
Biogen Stock: Biogen Announces $7.3 Billion Acquisition Of Reata ...
Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio
FDA approves new Biogen treatment for rare form of ALS
The Biogen Logo History, Colors, Font, And Meaning
The Biogen headquarters in Cambridge, Massachusetts, US, on Tuesday ...
Manufacturing | Biogen
Biogen commits $2b to modernise US manufacturing facility - Drug ...
Blueprint to Biogen: A map for Selling to Biogen
Biogen Duo System | INOS
Biogen alcanza los 9.800 millones de dólares de ingresos en 2023, un 3% ...
Biogen International | Biogen
Biogen taps Chinese biotech InnoCare in $125M midstage MS drug pact ...
Biogen invests $2B in U.S. manufacturing — but not in Massachusetts ...
Biogen Plans Global Manufacturing Upgrades | Manufacturing.net
Biogen Q4 Results Top Estimates
How a Biogen drug set the stage for a new biotech targeting ALS ...
Biogen Bolsters Immune Disease Pipeline with $1.8 Billion Acquisition ...
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Biogen to buy immunology startup HI-Bio, set up Bay Area team - San ...
Biogen Logo
Making Medicines Safely & Reliably | Biogen
Biogen tops quarterly profit estimates, eyes deals to build early-stage ...
Biogen Stock Dips After Biotech Company Unveils Plans In ALS Treatment ...
Biogen taps Envisagenics' AI to speed up RNA splicing R&D | pharmaphorum
Driven by Leqembi, Biogen beats Q2 expectations, raises full-year outlook
How Does Biogen Company Work? – SWOTTemplate.com
Biogen acquires Apellis Pharmaceuticals for $5.6 billion - Boston ...
Biogen signs agreement to acquire Reata for $7.3bn | Pharmaceutical ...
Environment | Biogen
WATCH: Shares of Biogen were on track to add more than $10 billion to ...
Biogen investing $2B to expand operations in RTP - ABC11 Raleigh-Durham
Investors Research Corp Takes Position in Biogen Inc. $BIIB
2024 Corporate Responsibility Report | Biogen
Biogen Idec Headquarters
In dramatic turn, Biogen seeks FDA approval for experimental Alzheimer ...
Biogen Beefs Up Immuno Pipeline with Potential $1.8B HI-Bio Acquisition ...
Biogen Inc. to Acquire Rare Disease Drugmaker Reata Pharmaceuticals in ...
Biogen announced that they have entered into an agreement whereby ...
Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi ...
Biogen gets FDA Breakthrough status for felzartamab | Biotechnology ...
Biotech group Biogen boosted by sales of key drugs | Financial Times
1 Year Later: The Biogen ‘Superspreader’ Conference That Sparked Boston ...
Biogen Breaks Out On 'Clean Quarter' Amid Drug Wins, Guidance Boost
Biogen acquires Reata and cuts 1,000 jobs - Drug Discovery World (DDW)
Biogen in up to $1.8 bln deal as rare diseases take center stage ...
Biogen confident in Alzheimer's drug ahead of rivals' data | Reuters
Biogen races into phase 3 with Spinraza follow-up | pharmaphorum
Biogen Inc. vs. Amgen: Which Big Biotech Is the Smarter Buy Today ...
Biogen - Biogen Stock Rockets To Record High On Alzheimer S Approval 5 ...
Biogen Headquarters And Global Offices
Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in ...
Biogen vs Regeneron Pharmaceuticals | Comparably
Biogen Foundation Celebrates Grantee MassBioEd’s Impact for 20th ...
Samsung in Talks to Buy Alzheimer’s Drug Maker Biogen for $42 Billion ...
Careers | Biogen
Former J&J executive emerges as front-runner for Biogen top job - STAT ...
Biogen Is Adding ALS Drugs to Its Research Pipeline in Search of ...
Biogen Jobs and Company Culture
Change at top for Mass.-based Biogen after Alzheimer's drug flops
323 Biogen Photos & High Res Pictures - Getty Images
Biogen is Preparing for the Largest Layoff in Company History！
Biogen opens a branch in Estonia: Europe has lots to learn from Estonia ...
Biogen Profit Easily Tops Views - WSJ
Biogen tops earnings expectations, but still has some longer-term ...
Leadership shift sets Biogen ANZ on course for next-phase growth ...
Biogen to acquire privately held Human Immunology Biosciences for $1.15 ...
Biogen Partners With InnoCare To Keep Up With BTK Inhibitor Leaders in MS
Biogen scores FDA approval for generic eye disease biologic, a ...
Working at Biogen | Glassdoor
Top Vertex Pharmaceuticals Competitors: A Biotech Analysis
Top 10 Best Biotechnology Companies In USA 2023 - Inventiva
全球首款！FDA批准Biogen反义核苷酸疗法上市，治疗渐冻症！_摩熵医药(原药融云)
Biogen: Biotech Bargain - Barron's
In this photo illustration, the American multinational biotechnology ...
What We Will Look Like...The Organizational Structure
Healthcare Professionals
Working At Biogen: Company Overview and Culture - Zippia
Biogen's antisense ALS drug shows promise in early clinical trial ...
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eye ...
Biogen: Now That’s More Like It! | Barron's
Home [biogen-uk-ie.com]
Biogen's Turnaround Is Still Waiting In The Wings As…
Ground breaking: Biogen’s $200M RTP gene therapy facility means new ...
For Biogen, ‘a massive destruction of market value’ - The Boston Globe
Biogen's results beat estimates on strength in rare disease drugs | Reuters
Johnson & Johnson vs Biogen: Evaluating Growth and Stability for Investors
FDA Approves Biogen’s Drug for Rare Form of ALS - The New York Times
A Look Inside Biogen’s New Lisbon Office - Officelovin'
Jacobs wins contracts with Biogen, NASA - L.A. Business First
:max_bytes(150000):strip_icc()/GettyImages-1742678123-27c9d18e27274ea7a0a3ff747178c5bb.jpg)
